Page 45 - GlaxoSmithKline Pharmaceuticals AR 2012

41
Notes to the Financial Statements for the year ended 31st December, 2012 — continued
3 RESERVES AND SURPLUS
Rupees in lakhs
As at
31st December
2011 Additions Deductions
As at
31st December
2012
Capital Reserve .. .. .. .. 1,65.51 — — (b) 1,65.51
Capital Redemption Reserve .. .. 2,61.95 — — (c) 2,61.95
General Reserve .. .. .. .. 720,36.57 (a) 57,72.59 — 778,09.16
724,64.03 57,72.59 782,36.62
Surplus in Statement of Profit and Loss .. .. .. 1110,59.15 577,25.89 (544,90.44) 1142,94.60
Balance as at the beginning of the year .. 1110,59.15
Profit for the year as per Statement of Profit
and Loss .. .. .. .. 577,25.89
Less : Appropriations :
Proposed Dividend .. .. .. (423,51.50)
Tax on distributed profit .. .. (63,66.35)
Transfer to General Reserve .. .. (57,72.59)
Balance as at the end of the year .. 1142,94.60
TOTAL .. 1835,23.18 634,98.48 (544,90.44) 1925,31.22
(a) Transfer from Surplus in Statement of Profit and Loss.
(b) Includes Central Government subsidy Rs. 15.00 lakhs and capital profit on reissue of shares forfeited of erstwhile Burroughs
Wellcome (India) Limited Rs. 0.51 lakhs.
(c) On account of buy back of equity shares.
Previous year
Rupees
in lakhs
Rupees
in lakhs
4 LONG TERM BORROWINGS
Interest free sales tax loan from SICOM Limited.. .. .. .. .. 4,14.24 4,59.33
TOTAL .. 4,14.24 4,59.33
Terms of repayment
Interest free Sales Tax Loan from SICOM Limited as at 31st December, 2012 of Rs. 4,59.33 lakhs (Previous year – Rs. 4,90.52 lakhs)
includes Rs. 20.94 lakhs (Previous year – Rs. 42.78 lakhs) availed under the 1988 Sales Tax deferment Scheme repayable in three
installments, closing on 31st January, 2014 and Rs. 4,38.39 lakhs (Previous year – Rs. 4,47.74 lakhs) under the 1993 Sales Tax
deferment Scheme repayable in twenty nine instalments closing on 30th April, 2021. The current maturity amount of Rs. 45.09 lakhs
(Previous year – Rs. 31.19 lakhs) of the loan has been disclosed under Note 8 – Other Current Liabilities.